Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations

Based on methodological considerations and the empirical findings in our case study, we expect the superiority of classification trees for the derivation of ITRs to be generalizable to other microsimulation models. This finding needs to be confirmed in future applications. Stochastic uncertainty has significant impacts on the ITRs, such that accurate representations of individual patient pathways are particularly crucial when designing ITRs. Future research could explore further empirical models and analytical approaches for ITRs or consider the translation of ITRs into the real-world decision-making context.

Authors

Institutions

Publication Details

Journal
PharmacoEconomics
Published
2025-11-10
DOI
https://doi.org/10.1007/s40273-025-01562-4
Citations
1
Primary Topic
Machine Learning in Healthcare
Type
article
Field-Weighted Citation Impact
2.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations

Ana Cecilia Quiroga Gutiérrez, Niklaus Meier, Mark Pletscher, Matthias Schwenkglenks
1 citations
PharmacoEconomics
Machine Learning in Healthcare
2.48
article

Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations

Ana Cecilia Quiroga Gutiérrez, Niklaus Meier, Mark Pletscher, Matthias Schwenkglenks
article en
1 citations

Abstract

Based on methodological considerations and the empirical findings in our case study, we expect the superiority of classification trees for the derivation of ITRs to be generalizable to other microsimulation models. This finding needs to be confirmed in future applications. Stochastic uncertainty has significant impacts on the ITRs, such that accurate representations of individual patient pathways are particularly crucial when designing ITRs. Future research could explore further empirical models and analytical approaches for ITRs or consider the translation of ITRs into the real-world decision-making context.

PharmacoEconomicsVol. 44(4)
Novartis (Switzerland) (CH), Bern University of Applied Sciences (CH), University of Basel (CH)
Openalex Percentile: Top 8%
Machine Learning in Healthcare
2.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.